Bicocca Open Archive

Logo unimib boa
STRAZZABOSCO, MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 31.847
AS - Asia 15.348
EU - Europa 12.145
SA - Sud America 2.102
Continente sconosciuto - Info sul continente non disponibili 1.040
AF - Africa 336
OC - Oceania 37
Totale 62.855
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 29.796
SG - Singapore 5.355
CN - Cina 3.489
IT - Italia 2.585
HK - Hong Kong 2.140
VN - Vietnam 1.997
RU - Federazione Russa 1.930
CA - Canada 1.832
SE - Svezia 1.637
BR - Brasile 1.566
DE - Germania 1.351
IE - Irlanda 1.251
UA - Ucraina 1.151
GB - Regno Unito 680
FR - Francia 475
IN - India 448
BD - Bangladesh 396
FI - Finlandia 381
KR - Corea 318
AR - Argentina 205
TR - Turchia 193
IQ - Iraq 181
AT - Austria 121
ZA - Sudafrica 118
NL - Olanda 113
MX - Messico 110
DK - Danimarca 106
ID - Indonesia 106
PK - Pakistan 105
JP - Giappone 102
ES - Italia 84
SA - Arabia Saudita 80
EC - Ecuador 78
CO - Colombia 75
PH - Filippine 65
PL - Polonia 58
VE - Venezuela 57
UZ - Uzbekistan 56
MA - Marocco 51
BE - Belgio 46
CL - Cile 42
MY - Malesia 37
JM - Giamaica 31
KE - Kenya 30
PY - Paraguay 29
JO - Giordania 28
BG - Bulgaria 27
CZ - Repubblica Ceca 27
EU - Europa 27
AU - Australia 26
TW - Taiwan 26
AE - Emirati Arabi Uniti 25
NP - Nepal 24
TN - Tunisia 24
IR - Iran 23
ET - Etiopia 21
PE - Perù 20
DZ - Algeria 19
EG - Egitto 19
AZ - Azerbaigian 18
CH - Svizzera 18
CR - Costa Rica 17
RO - Romania 17
UY - Uruguay 17
LT - Lituania 16
OM - Oman 16
IL - Israele 14
KZ - Kazakistan 14
PS - Palestinian Territory 14
TH - Thailandia 14
TT - Trinidad e Tobago 12
HN - Honduras 11
BO - Bolivia 10
DO - Repubblica Dominicana 10
SN - Senegal 10
NZ - Nuova Zelanda 9
LB - Libano 8
MD - Moldavia 8
NO - Norvegia 8
RS - Serbia 8
BH - Bahrain 7
BY - Bielorussia 7
HU - Ungheria 7
KG - Kirghizistan 7
KW - Kuwait 7
PT - Portogallo 7
GA - Gabon 6
GT - Guatemala 6
MN - Mongolia 6
NI - Nicaragua 6
AL - Albania 5
GE - Georgia 5
GR - Grecia 5
MM - Myanmar 5
SC - Seychelles 5
SY - Repubblica araba siriana 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BB - Barbados 4
HR - Croazia 4
PA - Panama 4
Totale 61.774
Salva come PNG Salva come JPEG
Città #
Ann Arbor 3.259
Singapore 3.046
Woodbridge 2.789
Ashburn 2.723
Fairfield 2.114
Hong Kong 2.098
Houston 1.925
Toronto 1.418
Chandler 1.335
San Jose 1.263
Jacksonville 1.221
Dublin 1.214
Wilmington 1.002
Seattle 884
Frankfurt am Main 852
Milan 796
Cambridge 770
New York 739
Ho Chi Minh City 585
Dearborn 557
Princeton 534
Santa Clara 527
Beijing 475
Hanoi 456
Chicago 435
Hefei 435
The Dalles 433
Los Angeles 369
Dallas 364
Nanjing 293
Seoul 292
Lauterbourg 249
Lawrence 228
Rome 225
Council Bluffs 222
Altamura 204
Lachine 197
Shanghai 195
Buffalo 168
Boardman 153
Helsinki 146
São Paulo 137
Moscow 134
San Diego 131
Guangzhou 114
Orem 90
Shenyang 90
Vienna 89
Da Nang 87
Nanchang 77
Andover 76
Baghdad 75
Changsha 71
Columbus 67
Tokyo 67
London 66
Ottawa 64
Philadelphia 64
Hebei 63
Haiphong 62
Brooklyn 58
Falls Church 57
Rio de Janeiro 57
Tianjin 57
Hangzhou 56
Montreal 53
Jiaxing 50
Johannesburg 49
Norwalk 49
Dong Ket 47
Munich 47
Chennai 46
Figino 45
Fremont 45
Jakarta 45
Mountain View 45
Jinan 44
Boston 42
Dhaka 42
Tashkent 42
Nuremberg 41
Salt Lake City 41
Warsaw 41
Atlanta 39
Washington 39
Zhengzhou 39
Denver 37
Brasília 36
Brussels 36
Huizen 36
Pune 36
Bologna 35
Hải Dương 35
Kunming 35
Phoenix 35
Tampa 35
Turin 35
Belo Horizonte 33
San Francisco 33
Elk Grove Village 32
Totale 40.519
Salva come PNG Salva come JPEG
Nome #
Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma 684
Impact of multidisciplinary team approach to liver tumors: 5-Years experience 528
Impact of multidisciplinary team approach to liver tumors in a tertiary center: 5-years experience 496
Effect of Silibinin on biliary lipid composition. Experimental and clinical study 486
Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology 466
JNK SIGNALING ACTIVATED BY PLATELET-DERIVED GROWTH FACTOR D (PDGF-D) STIMULATES SECRETION OF VASCULAR ENDOTHELIAL GROWTH FACTOR-C (VEGF-C) BY CANCER-ASSOCIATED FIBROBLASTS TO PROMOTE LYMPHANGIOGENESIS AND EARLY METASTATIZATION IN CHOLANGIOCARCINOMA 430
Diagnostic Value of Quantitative Perfusion Computed Tomography Technique in the Assessment of Tumor Response to Sorafenib in Patients with Advanced Hepatocellular Carcinoma 399
Resveratrol impairs glioma stem cells proliferation and motility by modulating the wnt signaling pathway 394
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 392
Inheritance of hyperbilirubinemia: evidence for a major autosomal recessive gene. 379
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 368
Long term outcome of acute pancreatitis in Italy: Results of a multicentre study 354
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 348
Health related quality of life in chronic liver diseases 344
Dynamic contrast enhanced perfusion CT imaging: A diagnostic biomarker tool for survival prediction of tumour response to antiangiogenetic treatment in patients with advanced HCC lesions 328
Trattamento con Sofosbuvir e Ribavirina nei pazienti hcv-positivi listati per il trapianto di fegato: un analisi di costo-efficacia 326
Diagnostic value of dynamic contrast-enhanced CT with perfusion imaging in the quantitative assessment of tumor response to sorafenib in patients with advanced hepatocellular carcinoma: A feasibility study 326
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 325
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 324
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 319
HCC persistence or recurrence after bridging therapy helps predict transplant list dropout and generate a more equitable exception policy 317
Valproic Acid Inhibits Proliferation and Reduces Invasiveness in Glioma Stem Cells Through Wnt/β Catenin Signalling Activation 316
Outcome Indicators in Primary Sclerosing Cholangitis: Interim Analysis Of The Value-Based Medicine In Hepatology (VBMH) Study 313
P1169 : Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 309
The impact of liver disease on the health-related quality of life 309
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 306
Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice 305
A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases 295
P0811 : Sofosbuvir-based direct-acting antivirals treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 293
Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium 293
Generation and Performance of Outcome Indicators in Liver Cirrhosis: The Value Based Medicine in Hepatology Study (V.B.M.H.) 292
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study) 292
Measurement of clinical outcomes and quality of life indicators as a new value-based approach to liver cirrhosis management 292
Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis 292
Cholangiocyte biology as relevant to cystic liver diseases 291
Low-dose paclitaxel reduces S100A4 nuclear import to inhibit invasion and hematogenous metastasis of cholangiocarcinoma 290
Subcutaneous insulin infusion (CSII) in italy: The third national survey [La terapia insulinica sottocutanea continua (CSII) in Italia. Terza indagine nazionale] 289
Characteristics of patients with Chronic Hepatitis C who have failed past treatment or who have never been treated: How much room left for Interferon? 286
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies 285
Impatto dei farmaci anti virali ad azione diretta sulla cura dei pazienti con epatite C: un approccio di value-based medicine 285
Notch signaling regulates tubular morphogenesis during repair from biliary damage in mice 280
The optimal timing of hepatitis C therapy in liver transplant-eligible patients: Cost-effectiveness analysis of new opportunities 278
A value-based approach to the management of patients with liver cirrhosis through the systematic measurement of clinical outcome and quality of life indicators 277
Difference in health related quality of life of chronic liver diseases and general population 277
"The city of Hepar": Rituals, gastronomy, and politics at the origins of the modern names for the liver 275
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life 275
ERK1/2-dependent vascular endothelial growth factor signaling sustains cyst growth in polycystin-2 defective mice 274
Health Related Quality of Life in the Major Liver Conditions 274
Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the " Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease 272
Value-based approach to hepatocellular carcinoma: outcome indicators tested in a large multicenter study (VBMH study) 271
Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness 271
Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma? 270
The cystic fibrosis transmembrane conductance regulator controls biliary epithelial inflammation and permeability by regulating Src tyrosine kinase activity 270
Ursodeoxycholic acid stimulates cholangiocyte fluid secretion in mice via CFTR-dependent ATP secretion. 268
Liver-allocation policies for patients affected by HCC in Europe 268
Epithelial expression of angiogenic growth factors modulate arterial vasculogenesis in human liver development 267
Morphological and functional features of hepatic cyst epithelium in autosomal dominant polycystic kidney disease. 267
Models of The Impact of Major Liver Diseases on Eq-5d Visual Analogue Scale and Utility-Index: Convergences and Divergences 266
Management of treatment-naïve chronic hepatitis C genotype 1 patients: A cost-effectiveness analysis of treatment options 264
The challenges of primary biliary cholangitis: What is new and what needs to be done 263
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching 262
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis 261
Procoagulant phenotype of virus-infected pericytes is associated with portal thrombosis and intrapulmonary vascular dilations in fatal COVID-19 260
The cholangiopathies: disorders of biliary epithelia 260
Functional anatomy of normal bile ducts 259
Continuous subcutaneous insulin infusion in Italy: Third national survey 259
Loss of CFTR affects biliary epithelium innate immunity and causes TLR4NF-κB-mediated inflammatory response in mice 258
Foxa1 and Foxa2 regulate bile duct development in mice 257
Sofosbuvir-based all-oral treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 256
Cholangiocyte pathobiology 256
Animal models of cholestasis: An update on inflammatory cholangiopathies 255
Effect of age on single- and multiple-dose pharmacokinetics of erythromycin 254
Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling 253
PGI31 Health Care Indicators to Measure Quality of Care in Patients with Liver Diseases 253
pka-dependent p-ser- 675 β-catenin phosphorylation increases cholangiocyte motility in pkhd1del4/del4 mice, a model of fibropolycystic liver diseases caused by defective fibrocystin function 253
Pka-dependent p-ser-675-catenin phosphorylation increases cholangiocyte motility in a mouse model of fibropolycystic liver diseases 253
Should new antiviral treatments be considered in elderly Chronic Hepatitis C patients? 253
Effect of Silybin on biliary lipid composition in rats 252
Revisiting Epithelial-to-Mesenchymal Transition in Liver Fibrosis: Clues for a Better Understanding of the "reactive" Biliary Epithelial Phenotype 251
JNK SIGNALING ACTIVATED BY PLATELET-DERIVED GROWTH FACTOR D (PDGF-D) STIMULATES SECRETION OF VASCULAR ENDOTHELIAL GROWTH FACTOR-C (VEGF-C) BY CANCER-ASSOCIATED FIBROBLASTS TO PROMOTE LYMPHANGIOGENESIS AND EARLY METASTASIZATION IN CHOLANGIOCARCINOMA 250
Molecular mechanisms driving cholangiocarcinoma invasiveness: an overview 249
Should Sofosbuvir-Based All-Oral Treatment Be Considered In Elderly Chronic Hepatitis C Patients? 248
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. 247
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 247
Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2-/- mice 246
Sorafenib paradoxically activates the raf/mek/erk signaling in mice with polycystic liver disease (pld) caused by conditional deletion of polycystin-2 246
Applicazione della value-based medicine nella valutazione della cura dei pazienti affetti da epatite. 246
Intracellular alkalinization stimulates bile flow and vesicular-mediated exocytosis in IPRL 245
Cyclic AMP/PKA-dependent paradoxical activation of Raf/MEK/ERK signaling in polycystin-2 defective mice treated with sorafenib 245
Β-Catenin-Mediated Cxcl1 and Cxcl10 Secretion by Fibrocystin-Defective Cholangiocytes Regulates Peribiliary Recruitment of Fibrocytes in Congenital Hepatic Fibrosis 245
Notch signaling and progenitor/ductular reaction in steatohepatitis 245
Combined double lung-liver transplantation for cystic fibrosis without cardio-pulmonary by-pass. 241
Monocyte/macrophage peribiliary recruitment by pkhd1-defective cholangiocytes induces expression of avb6 integrin on biliary cysts via tgf-β1 and tnf-α in congenital hepatic fibrosis 240
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 240
Intracellular pH regulation in isolated rat bile duct epithelial cells 239
PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases 238
Isolated idiopathic bile ductular hyperplasia in patients with persistently abnormal liver function tests 237
Novel association of HLA-haplotypes with primary sclerosing cholangitis (PSC) in a southern European population 236
Purinergic regulation of acid/base transport in human and rat biliary epithelial cell lines. 236
Notch signaling and new therapeutic options in liver disease 236
Totale 29.360
Salva come PNG Salva come JPEG
Categoria #
all - tutte 207.571
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 207.571
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.747 0 293 499 219 101 210 133 197 143 199 244 509
2022/20235.338 594 1.602 470 404 435 810 72 278 369 31 178 95
2023/20243.783 151 142 112 179 505 1.038 764 139 333 33 24 363
2024/20258.323 551 1.073 423 324 775 275 522 405 757 1.178 652 1.388
2025/202620.968 2.210 1.393 1.359 1.726 2.090 1.183 2.554 1.068 1.823 1.932 2.015 1.615
2026/20271.206 756 450 0 0 0 0 0 0 0 0 0 0
Totale 62.855